Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:3D-brahiterapija raka materničnega vratu na podlagi magnetnoresonančnega slikanja
Authors:ID Petrič, Primož (Author)
ID Hudej, Robert (Author)
ID Marolt-Mušič, Maja (Author)
Files:.pdf PDF - Presentation file, download (481,05 KB)
MD5: 99FC96BE3878687D4C4CB6C43B5C68C3
PID: 20.500.12556/dirros/ce76563d-b323-471e-be5f-dbf665070cac
 
Language:Slovenian
Typology:1.04 - Professional Article
Organization:Logo OI - Institute of Oncology
Publication status:Published
Publication version:Version of Record
Year of publishing:2008
Number of pages:str. 46-51
Numbering:Letn. 12, št. 1
PID:20.500.12556/DiRROS-8750 New window
UDC:616-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-D2D5XVA9
COBISS.SI-ID:617339 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:4236
Downloads:1034
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:Undetermined
Title:MRI-based 3D Brachytherapy for Cervical Cancer
Abstract:Brachytherapy, in combination with external beam radiotherapy and chemotherapy, plays an essential role in radical treatment of locally advanced cervical cancer. Implementation of MRI based treatment planning and individual optimization of dwell-times and dwell-positions of 192Ir pulsed- and high-dose rate stepping sources enables dose escalation in the target volume while respecting normal tissue tolerance. Development of novel combined intracavitary/interstitial applicators allows for an accurate, reproducible and individualized insertion of a low number of needles into the parametria to achieve an adequate target coverage in tumors with unfavorable topography. When compared to standard, Manchester point »A« based method, these innovative approaches result in improved local control without increasing side effects rates


Archive

niGradiv

Back